Regulatory T cells safeguard liver health during metabolic-associated steatohepatitis
Open accessAbstract
Metabolic-dysfunction-associated steatohepatitis (MASH) is a chronic liver disease driven by the confluence of metabolic stress and destructive inflammation. The immunoregulatory mechanisms that temper this process remain poorly understood. Multipronged data on a complementary pair of murine MASH models and published single-cell RNA-sequencing datasets from MASH patients revealed a critical protective role for Foxp3 + CD4 + regulatory T cells (Tregs) in MASH. Tregs progressively accumulated in diseased livers, adopting an activated, nonlymphoid-tissue phenotype marked by expression of the transcription factor Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) as well as a reparative transcriptional program. Punctual ablation of Tregs during established MASH unleashed a catastrophic inflammatory cascade, including exaggerated T-helper (Th)1, Th2, and Th17 responses, expansion of a pathogenic CD8 + T cell population, and hepatocellular injury. Concomitantly, Treg deficiency disrupted key metabolic pathways in the liver, accelerating disease progression. These findings establish Tregs as nonredundant custodians of both immunologic and metabolic homeostasis in the liver, highlighting their promise as targets for temporally tuned immunoregulatory therapies in metabolic liver disease.
AI snapshot
Written from the paper’s full text.
TL;DR
In mouse models of MASH and published human single-cell data, liver regulatory T cells expand and shift toward an activated, PPARγ-associated reparative state. Acutely removing these cells worsens hepatic inflammation, injury, and metabolic disruption, supporting a nonredundant protective role during MASH.
Key findings
- Hepatic Tregs increased in both CDAHFD- and AMLN-fed mice; in CDAHFD they peaked around week 4 and later contracted, while in AMLN the rise became evident after about 20 weeks. Human MASH liver scRNA-seq datasets also showed a higher Treg frequency than controls.
- Liver Treg transcriptomes changed substantially: 195 genes up and 154 down in CDAHFD, and 284 up and 157 down in AMLN. Shared changes included activation, immunosuppressive, TCR-signaling, and tissue-residency markers, with reduced naive-Treg markers and enrichment of an eVAT-like/PPARγ signature.
- Single-cell profiling resolved four liver Treg subtypes—naive, Itgb1+, Pparg− reparative, and Pparg+ reparative—with CDAHFD expanding the reparative clusters, especially the PPARγ+ one. Deleting Pparg in Tregs did not significantly change their frequency or number in healthy or MASH livers, though PD-1hi Tregs were modestly lower in CDAHFD-fed mice.
- Acute Treg depletion in CDAHFD- and AMLN-fed mice increased CD4 conventional and CD8 T cells, Th1/Th2/Th17-associated markers and cytokines, inflammatory myeloid populations, and PD-1/CXCR6 on CD8 T cells. Liver RNA-seq found 380 genes changed, with suppressed metabolic modules and enriched inflammatory/fibrotic programs, alongside higher plasma ALT/AST and hepatic triglycerides.
Methods
- Used C57BL/6J, Foxp3Gfp, Foxp3Cre.Ppargflox/flox, PpargTdt reporter, and Foxp3-Dtr mice; MASH was induced with CDAHFD or AMLN diets versus low-fat control diets, with diphtheria toxin used for timed Treg depletion.
- Collected liver leukocytes for flow cytometry, sorted Tregs for population-level and single-cell RNA-seq, performed whole-liver bulk RNA-seq including a disease time course, and reanalyzed two published human MASH scRNA-seq datasets.
- Main analyses included differential expression, pathway and gene-set enrichment, single-cell clustering, transcript-density comparisons, and co-regulated gene-module analysis.
Limitations
- Stated: the authors cannot exclude systemic effects of Treg depletion beyond the liver; PPARγ may have functions not assayed; the importance of amphiregulin in human MASH is uncertain; and conflicting prior results may reflect constitutive broad Treg depletion causing systemic metabolic changes.
- Evident from the text: human evidence is limited to reanalysis of published scRNA-seq rather than functional perturbation, and the work relies on dietary mouse models plus acute depletion, leaving long-term effects of sustained Treg accumulation and subtype-specific fibrosis promotion unresolved.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
9 of 10 cited sources checked · 2 supported · 0 flagged · accuracy not yet measured
- Findingown data
In human single-cell RNA-sequencing datasets, Treg frequency is significantly higher in MASH livers than in control livers.
“Notably, the Treg frequency was significantly elevated in MASH livers relative to that of controls (Fig. 1E), echoing the Treg enrichment observed in the CDAHFD and AMLN models.”
Quote in the paperSubstantial claim2 of 2 sources checked- cites [22] source
Extended Data Figure 3 compares T-cell and innate lymphoid-cell fractions in healthy versus cirrhotic livers, but the available text does not report a significant increase in Tregs in MASH livers. Extended Data Figure 7 examines NASH liver samples, but its frequency analysis concerns scar-associated macrophages, not Tregs. Searches for Treg and regulatory T cells found no passage establishing the claimed comparison. (LLM, conf=0.76)
Experimental — accuracy not yet measured - cites [23] source
The ‘Augmented CD8+PD1+ T cells in human-NASH’ section reports human liver scRNA-seq and enrichment of CD8+PD1+ T cells, not Treg cells. Its Fig. 3 legend identifies Treg cells but gives no comparison of their frequency between NASH and control livers. Searches for elevated Treg frequency and regulatory T-cell enrichment found no passage establishing the claimed significant difference. (LLM, conf=0.76)
Experimental — accuracy not yet measured
- Findingown data
In published single-cell RNA-sequencing datasets from MASH patient livers, FOXP3+ cells expressing canonical Treg transcripts such as IL2RA, CTLA4, and TNFRSF18 are present.
“Focusing our analysis on the CD4+ T cell compartment, we identified FOXP3+ cells expressing canonical Treg cell transcripts, including IL2RA, CTLA4 and TNFRSF18 (Fig. 1D, right panel).”
Quote in the paperSubstantial claim2 of 2 sources checked- cites [22] source
Extended Data Figure 3 describes single-cell analysis of liver T cells from five healthy and five cirrhotic donors, so the paper provides a relevant T-cell dataset. It does not report FOXP3+ cells coexpressing IL2RA, CTLA4 and TNFRSF18. Its NASH analysis in Extended Data Figure 7 uses whole-liver microarray data, not a NASH-specific single-cell T-cell dataset. (LLM, conf=0.84)
Experimental — accuracy not yet measured - cites [23] source
The ‘Augmented CD8+PD1+ T cells in human-NASH’ section and Fig. 3 caption describe single-cell RNA-sequencing of liver T cells from patients with NAFLD or NASH; the caption also mentions Treg cells. Neither those passages nor the human scRNA-seq Methods report FOXP3+ cells co-expressing IL2RA, CTLA4 and TNFRSF18, so the specific cell-marker finding is not established by our copy. (LLM, conf=0.78)
Experimental — accuracy not yet measured
- Findingown data
Acute Treg depletion in CDAHFD-fed mice triggers a marked increase in hepatic immune cell numbers, most prominently CD4+ Tconv and CD8+ T cells.
“This acute loss of Tregs triggered a marked increase in hepatic immunocyte numbers, most prominently numbers of CD4+ T conventional (Tconv) cells and CD8+ T cells (Fig. 5B), accompanied by elevated proliferation according to Ki-67 staining (Fig. 5C).”
Quote in the paperSubstantial claim - Findingown data
In Treg-deficient livers, metabolic pathways, particularly bile-acid and fatty-acid metabolism, are suppressed.
“In contrast, metabolic pathways, particularly those related to bile-acid and fatty-acid metabolism, were suppressed.”
Quote in the paperSubstantial claim - Findingown data
The Itgb1+ Treg cluster is marked by S100a10−, S100a4−, Slamf6−, and S1P-receptor-encoding transcripts S1pr1 and S1pr4.
“The Itgb1+ cluster was marked by S100a10−, S100a4−, Slamf6-, and S1P-receptor-encoding (S1pr1, S1pr4) transcripts.”
Quote in the paperNot a substantial claim
- Findingown data
Expression of the activation markers CD44 and CXCR6 on liver Tregs remains unchanged under CDAHFD and LFD conditions in PpargΔTreg mice.
“Expression of other activation markers, including CD44 and CXCR6, remained unchanged under the two feeding conditions (Fig. 4D, E).”
Quote in the paperNot a substantial claim - Findingown data
Acute Treg depletion in CDAHFD-fed mice is accompanied by elevated proliferation according to Ki-67 staining.
“This acute loss of Tregs triggered a marked increase in hepatic immunocyte numbers, most prominently numbers of CD4+ T conventional (Tconv) cells and CD8+ T cells (Fig. 5B), accompanied by elevated proliferation according to Ki-67 staining (Fig. 5C).”
Quote in the paperSubstantial claim - Findingown data
Single-cell RNA-sequencing of liver Tregs from CDAHFD-fed and control Foxp3Gfp mice resolves four discrete subtypes: naïve, Itgb1+, Pparg− reparative, and Pparg+ reparative.
“Integrated cell-clustering analysis of Tregs from the two conditions resolved four discrete subtypes: “naïve,” “Itgb1+,” “Pparg− reparative” and “Pparg+ reparative” (Fig. 3A).”
Quote in the paperSubstantial claim - Findingown data
Genes characteristic of naïve Tregs, including Ccr7, S1pr1, and Tcf7, are significantly downregulated in liver Tregs in both MASH models.
“In parallel, genes characteristic of naïve Tregs, including Ccr7, S1pr1 and Tcf7, were significantly downregulated in both models.”
Quote in the paperNot a substantial claim - Findingown data
In AMLN-fed mice, Treg depletion increases plasma transaminases and hepatic triglyceride content.
“Similarly, in AMLN-fed mice, Treg depletion increased plasma transaminases and hepatic triglyceride content (Fig. 6E).”
Quote in the paperSubstantial claim - Findingown data
In a transcriptomic time course of wild-type CDAHFD-fed mice, module C1, enriched for metabolic functions, is highest at baseline and progressively declines as disease unfolds.
“One module (C1), enriched for metabolic functions, was highest at baseline and progressively declined over disease unfolding.”
Quote in the paperNot a substantial claim - Findingown data
The distribution of other innate and adaptive T cell subsets is unaffected by Pparg deletion in Tregs.
“The distribution of other T cell subsets, both innate and adaptive, was likewise unaffected (SI Appendix, Fig. S3).”
Quote in the paperNot a substantial claim - Findingown data
Liver Tregs from both dietary MASH models acquire transcriptional features characteristic of nonlymphoid-tissue Tregs.
“As expected, liver Tregs from both dietary models acquired the characteristic transcriptional features of nonlymphoid-tissue Tregs (SI Appendix, Fig. S2A, B).”
Quote in the paperNot a substantial claim - Findingown data
Using Pparg-Tdt reporter mice, PPARγ+ Tregs are confirmed to be enriched in the liver after CDAHFD feeding.
“Using Pparg-Tdt reporter mice, we confirmed the enrichment of PPARγ+ Tregs in the liver after CDAHFD feeding (Fig. 4A).”
Quote in the paperSubstantial claim - Findingown data
Pparg deletion in Tregs has no significant effect on the frequency or absolute number of liver Tregs in either healthy mice or mice with MASH.
“Pparg gene deletion in Tregs had no significant effect on the frequency or absolute number of liver Tregs in either healthy mice or those with MASH (Fig. 4B).”
Quote in the paperSubstantial claim - Findingown data
Gene-set enrichment analysis shows a strong increase in inflammatory pathways, such as TNFα and IFN responses, in Treg-deficient livers.
“Gene-set enrichment analysis showed a strong increase in inflammatory pathways, such as responses to TNFα and IFN (Fig. 6B), consistent with our flow cytometric findings (Fig. 5E, K).”
Quote in the paperSubstantial claim - Findingown data
Similar results are obtained when Tregs are depleted at 8 weeks of CDAHFD feeding.
“Similar results were obtained when Tregs were depleted at 8 weeks of CDAHFD feeding (SI Appendix, Fig. S4C–G).”
Quote in the paperNot a substantial claim - Findingown data
Treg-activation-associated programs are significantly elevated in liver Tregs from both CDAHFD- and AMLN-fed mice.
“Treg-activation-associated programs were significantly elevated in Tregs from both CDAHFD- and AMLN-diet-fed mice (Fig. 2G, H), further confirming that MASH drives the hepatic Treg compartment toward an activated, eVAT-Treg-like state.”
Quote in the paperNot a substantial claim - Findingown data
The PPARγ− reparative Treg subtype expresses higher levels of Gzmb, Ccr2, Ccr3, and Icos.
“While the PPARγ− reparative subtype expressed higher levels of Gzmb, Ccr2, Ccr3 and Icos, its PPARγ+ counterpart was characterized by Pparg and Gata3 expression, as well as high levels of transcripts encoding co-stimulatory or co-inhibitory receptors (Pdcd1, Tnfrsf4, Tnfrsf9, Tnfrsf18) and TCR signaling molecules (Dusp1, Fosl2, Junb, Nr4a1–3, Fos, Jun), indicative of recent antigenic stimulation (”
Quote in the paperNot a substantial claim - Findingown data
In CDAHFD-fed mice, hepatic CD45+ immune cells accumulate within the first week of the enriched diet.
“Longitudinal profiling of CDAHFD-fed mice revealed an accumulation of hepatic immunocytes (CD45+ cells) already within the first week after introducing the enriched diet (SI Appendix, Fig. S1A).”
Quote in the paperNot a substantial claim - Findingown data
After Treg depletion, CD4+ Tconv cells produce the corresponding cytokines IFN-γ, IL-4/5/13, and IL-17A.
“They also produced the corresponding cytokines IFN-γ, IL-4/5/13 and IL-17A (Fig. 5E).”
Quote in the paperSubstantial claim - Findingown data
Bulk RNA-sequencing of livers from CDAHFD-fed mice after Treg depletion shows 380 genes significantly modulated compared with Treg-positive controls.
“380 genes were significantly modulated (Padj <0.05, |FC| >2) in Treg-deficient livers compared with Treg-positive controls (Fig. 6A).”
Quote in the paperSubstantial claim - Findingown data
After Treg depletion, CD4+ Tconv cells show elevated expression of Tbet, GATA3, and RORγt.
“Post-depletion, CD4+ Tconv cells exhibited elevated expression of Tbet, GATA3 and RORγt, supreme regulators of Th1, Th2 and Th17 cell differentiation (Fig. 5D).”
Quote in the paperSubstantial claim - Findingown data
CDAHFD-fed, Treg-deficient mice have elevated plasma ALT and AST.
“These molecular changes were accompanied by elevated measures of plasma Alanine Aminotransferase (ALT) and Aspartate Aminotransferase (AST) in CDAHFD-fed, Treg-deficient mice (Fig. 6D, SI Appendix, Fig. S5C).”
Quote in the paperSubstantial claim - Findingown data
After Treg depletion, CD8+ T cells display higher levels of PD-1 and CXCR6.
“CD8+ T cells displayed higher levels of PD-1 and CXCR6 (Fig. 5F), a phenotype that has been linked to autoaggressive cytotoxic lymphocytes implicated in hepatocyte injury during MASH development (14, 23).”
Quote in the paperSubstantial claim - Interpretationreasoning
Upregulation of TCR signaling genes in Tregs from MASH livers suggests that disease-associated antigens might drive their increased accumulation.
“The upregulation of TCR signaling genes in Tregs from MASH livers suggests that disease-associated antigens might drive their increased accumulation.”
Quote in the paperNot a substantial claim - Interpretationown data
Tregs substantially accumulate and adapt during MASH in both mice and humans.
“Our studies have uncovered a substantial accumulation and adaptation of Tregs during the course of MASH in both mice and humans.”
Quote in the paperSubstantial claim - Interpretationown data
PPARγ is largely dispensable for liver Treg accumulation, even under MASH-associated inflammatory stress.
“Thus, although PPARγ marks a transcriptionally distinct subset of liver Tregs, it is largely dispensable for their accumulation in the liver, even in the context of MASH-associated inflammatory stress.”
Quote in the paperSubstantial claim - Study design and conductown data
The effects of acute Treg depletion are not attributable to diphtheria toxin itself, because DT-treated Foxp3.Dtr− littermates show no such changes.
“These effects were not attributable to DT itself, as DT-treated Foxp3.Dtr− littermates showed no such changes (SI Appendix, Fig. S4A, B).”
Quote in the paperSubstantial claim - Interpretationown data
The murine liver Treg compartment in MASH adopts an activated, nonlymphoid-tissue-associated phenotype resembling that of eVAT Tregs.
“Beyond this increase, the murine liver Treg compartment adopted an activated, nonlymphoid-tissue-associated phenotype resembling that of eVAT Tregs.”
Quote in the paperSubstantial claim - Interpretationown data
Hepatic Tregs play a non-redundant role in restraining activation of both innate and adaptive immune cells.
“Functionally, hepatic Tregs played a non-redundant role in restraining the activation of both innate and adaptive immunocytes.”
Quote in the paperSubstantial claim - Interpretationreasoning
Tregs in the liver emerge as central regulators of immunologic tone in MASH.
“Alongside their established roles in eVAT, exercised skeletal muscle and systemic metabolic homeostasis (5, 25, 31–33), Tregs in the liver emerge as central regulators of the immunologic tone in MASH.”
Quote in the paperSubstantial claim - Interpretationown data
PPARγ is a phenotypic rather than functional marker of the PPARγ+ liver Treg population.
“Although hepatic Tregs in mice with MASH showed increased PPARγ expression, genetic perturbation studies indicated that it was largely dispensable for their accumulation, indicating that PPARγ is a phenotypic rather than functional marker of this population.”
Quote in the paperSubstantial claim
- May combine two claims. 22
- Classified as probably not a substantial claim. 2
May combine two claims.
PremisecitationThe function of hepatic regulatory T cells in MASH has been examined only rarely, and the small number of existing studies report contradictory findings, with some suggesting disease worsening and others suggesting a protective homeostatic role.
“In contrast, the role of hepatic Tregs in MASH has been explored only sparingly, and the limited studies available yield conflicting results, some implicating these cells in disease exacerbation, others attributing to them a protective, homeostatic function (18, 19).”
Quote in the paperSubstantial claim2 of 2 sources checkedMay combine two claims.
PremisecitationThe CDAHFD mouse diet produces rapid steatosis, inflammation, and fibrosis.
“The CDAHFD, which combines choline deprivation with a high-fat content and defined amino acid composition, elicits rapid-onset steatosis, inflammation, and fibrosis (20).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [20] source
May combine two claims.
FindingcitationBoth reparative Treg clusters express Areg and Il1rl1 and are enriched for an established reparative-Treg signature.
“Both reparative clusters expressed diagnostic Areg (encoding amphiregulin) and Il1rl1 (specifying the IL-33 receptor, ST2) transcripts and were enriched for an established reparative-Treg signature (SI Appendix, Table S1) (24).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [24] source
The Methods section on RNA sequencing describes signatures of TCR-dependent genes in Treg cells, not a reparative-Treg signature. Searches for Areg, Il1rl1, amphiregulin, ST2, and reparative Treg cells found no passage in our copy addressing the claimed markers or enrichment of the two clusters. No page number is available for these passages. (LLM, conf=0.76)
Experimental — accuracy not yet measured
May combine two claims.
InterpretationcitationThe numerical increase in hepatic Tregs in mice with MASH, also observed by single-cell RNA-sequencing in MASH patients, is consistent with recent reports of Treg enrichment in this setting.
“The numerical increase in hepatic Tregs in mice with MASH, also observed via scRNA-seq in MASH patients, is consistent with recent reports of Treg enrichment in such a setting (26).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [26] source
The passage on pioglitazone-treated, high-fat-diet-fed mice (section labeled Abstract; page unavailable) reports Treg enrichment in visceral fat, not liver. Our copy does not address hepatic Treg enrichment in MASH mice or scRNA-seq findings in MASH patients; searches for MASH, NASH, and liver Tregs found no passage establishing either point. (LLM, conf=0.75)
Experimental — accuracy not yet measured
May combine two claims.
Findingown dataLiver Tregs from both MASH models show strong enrichment for eVAT-Treg up- and down-signatures, including increased PPARγ-encoding gene expression, while lymphoid-tissue Treg signatures are further attenuated.
“Surprisingly, there was also strong enrichment for the established eVAT-Treg up- and down-signatures, including upregulation of the genes encoding the hallmark transcription factor, PPARγ (Fig. 2E, F); in contrast, the lymphoid-tissue Treg signatures were further attenuated (SI Appendix, Fig. S2A, B).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataMASH development extensively changes the liver Treg transcriptome in both mouse models, with 195 genes up and 154 down in CDAHFD-fed mice and 284 up and 157 down in AMLN-fed mice.
“In both models, MASH development led to extensive alteration of the liver Treg transcriptional profile: 195 genes upregulated and 154 downregulated in CDAHFD-fed mice; 284 upregulated and 157 downregulated in mice fed the AMLN diet (Fig. 2A, B).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataIn the same time course, module C2 (protein translation) rises within one week and remains elevated, C3 (ECM deposition/fibrosis) increases steadily to week 12, and C4 (inflammation) peaks at week 8 before declining.
“Three other modules (C2-C4) increased during CDAHFD feeding with distinct kinetics: C2 (protein translation) rose within one week and remained elevated; C3 (ECM deposition/fibrosis) increased steadily to week 12; and C4 (inflammation) peaked at week 8 before declining.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataTranscripts significantly upregulated in both diets include activation markers, immunosuppressive mediators, early TCR signaling components, and chemokine receptors linked to tissue residency.
“Transcripts significantly upregulated (padj <0.05, FC >2) in both diets encompassed activation markers (Tnfrsf9, Pdcd1, Cd81, Cd83), immunosuppressive mediators (Il10 and Fgl2), early TCR signaling components (Dusp1, Nr4a2, Fosl2), and chemokine receptors associated with tissue residency (Ccr8, Cxcr6).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe PPARγ+ reparative Treg subtype is characterized by Pparg and Gata3 expression and high levels of co-stimulatory/co-inhibitory receptor and TCR signaling transcripts, indicating recent antigenic stimulation.
“While the PPARγ− reparative subtype expressed higher levels of Gzmb, Ccr2, Ccr3 and Icos, its PPARγ+ counterpart was characterized by Pparg and Gata3 expression, as well as high levels of transcripts encoding co-stimulatory or co-inhibitory receptors (Pdcd1, Tnfrsf4, Tnfrsf9, Tnfrsf18) and TCR signaling molecules (Dusp1, Fosl2, Junb, Nr4a1–3, Fos, Jun), indicative of recent antigenic stimulation (”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataIn AMLN-fed mice, the rise in liver Treg numbers is delayed and becomes especially evident after 20 weeks.
“In the slower-evolving AMLN model, the increase in Treg numbers was delayed, becoming particularly evident after 20 weeks (Fig. 1C), in keeping with the protracted disease course.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataThe naïve Treg subtype expresses Sell, Ccr7, and Tcf7.
“The naïve Treg subtype, found in all tissue-Treg compartments so far examined, expressed Sell, Ccr7 and Tcf7.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThere are moderately fewer PD-1hi Tregs in CDAHFD-fed PpargΔTreg mice but not in LFD-fed mice.
“There were moderately fewer PD-1hi Tregs in mice fed CDAHFD but not those on LFD (Fig. 4C).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataIn CDAHFD-fed mice, liver Tregs expand in both frequency among CD4+ T cells and absolute number, peak at week 4, and then contract at later time points.
“Concomitantly, the population of Tregs expanded, both their frequency within the CD4+ T cell compartment and their absolute number (Fig. 1A), peaking at week 4 before contracting at later timepoints (Fig. 1B).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn AMLN-fed mice, Treg depletion at 20 weeks causes robust expansion of inflammatory myeloid populations, increased CD4+ Tconv and CD8+ T cell numbers, heightened proliferation, and broad enhancement of Th cell representation.
“A parallel approach in mice fed the AMLN diet for 20 weeks yielded analogous results: robust expansion of inflammatory myeloid populations (Ly6Chi macrophages, neutrophils), increased CD4+ Tconv cell and CD8+ T cell numbers (Fig. 5G–H), heightened proliferation, and a broad enhancement of Th cell representation (Fig. 5I–K).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn healthy mouse liver, naïve and Itgb1+ Treg subtypes predominate, whereas CDAHFD feeding drives pronounced expansion of the two reparative subtypes, most notably the PPARγ+ subtype.
“Transcript density analysis revealed the naïve and Itgb1+ Treg subtypes to predominate in the liver of healthy mice, while CDAHFD feeding drove a pronounced expansion of the two reparative subtypes, most notably that expressing PPARγ (Fig. 3D), pointing to a potentially specialized role for these cells in the inflamed liver.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataPPARγ+ Tregs are the most transcriptionally activated liver Treg subtype, characterized by high expression of genes encoding immunosuppressive and tissue-reparative molecules.
“Notably, PPARγ+ Tregs were the most transcriptionally activated liver Treg subtype, characterized by high expression of genes encoding immunosuppressive and tissue-reparative molecules.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataHepatic Tregs play a nonredundant role in restraining liver inflammation during MASH development, acting primarily to temper effector T cell responses within the liver.
“These findings demonstrate, then, that hepatic Tregs play a nonredundant role in restraining liver inflammation during the development of MASH, acting primarily to temper effector T cell responses within the liver.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataAcute Treg depletion is sufficient to trigger robust inflammatory responses characterized by increased effector T cell numbers, heightened tissue injury, and metabolic dysregulation.
“Acute depletion was sufficient to trigger robust inflammatory responses characterized by increased effector T cell numbers, heightened tissue injury and metabolic dysregulation.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataTregs are important for maintaining hepatic metabolic programs and for limiting inflammation and tissue injury during MASH progression.
“Collectively, these data indicate that Tregs are important for both maintaining hepatic metabolic programs and for limiting inflammation and tissue injury during MASH progression.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationThe AMLN diet causes a slower but steadily progressive MASH-like disease with hepatocellular ballooning, chronic inflammation, and fibrotic remodeling.
“In contrast, the AMLN diet, enriched in fat, fructose, and cholesterol, induces a slower but steadily progressive form of the disease, characterized by hepatocellular ballooning, chronic inflammation, and fibrotic remodeling (21).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [21] source
May combine two claims.
Interpretationown dataThe detrimental consequences of Treg loss in MASH are most likely driven by the local hepatic Treg compartment, although systemic effects cannot be excluded.
“Although the results from our temporally restricted Treg depletion experiments indicate that the detrimental consequences of Treg loss in MASH are most likely driven by the local hepatic Treg compartment, we cannot exclude contributions from systemic effects of Treg depletion, including altered extrahepatic inflammation or perturbations in systemic metabolism.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S2 (checkable). May combine two claims.
InterpretationreasoningThe results reinforce the therapeutic potential of Tregs in obesity-associated metabolic diseases while emphasizing the need for temporal and contextual precision in such manipulations.
“Our results therefore reinforce the therapeutic potential of Tregs in obesity-associated metabolic diseases, while also emphasizing the need for temporal and contextual precision in such manipulations.”
Quote in the paperNot a substantial claim- Rests on an assumption: Findings about Treg function in mouse MASH models translate sufficiently to human MASH to support therapeutic targeting of Tregs in metabolic liver disease.
May combine two claims.
InterpretationreasoningIt is likely that PPARγ+ Tregs are involved in Treg-driven protection in MASH, even if PPARγ itself is not required for their numerical maintenance.
“Given this profile, it is likely that these cells are involved in the Treg-driven protection in MASH, even if PPARγ itself is not required for their numerical maintenance.”
Quote in the paperSubstantial claim
The paper relies on this without support.
Findings about Treg function in mouse MASH models translate sufficiently to human MASH to support therapeutic targeting of Tregs in metabolic liver disease.
“These findings establish Tregs as non-redundant custodians of both immunologic and metabolic homeostasis in the liver, highlighting their promise as targets for temporally tuned immunoregulatory therapies in metabolic liver disease.”
Cites
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992 · cited 1× · see citing works
“Foxp3 IRES - GFP ( Foxp3 Gfp ) mice (37) were obtained from Dr V. Kuchroo (Brigham and Women’s Hospital, Boston, MA).”
Feuerer, M., Herrero, L., Cipolletta, D., Naaz, A., Wong, J., Nayer, A., Lee, J., Goldfine, A. B., Benoist, C., Shoelson, S., et al. (2009) · Nature Medicine · doi:10.1038/nm.2002 · Cited by 2,145 · see citing works
Self-citationResolving the fibrotic niche of human liver cirrhosis at single-cell level
Ramachandran, P., Dobie, R., Wilson-Kanamori, J. R., Dora, E. F., Henderson, B. E. P., Luu, N. T., Portman, J. R., Matchett, K. P., Brice, M., Marwick, J. A., et al. (2019) · Nature · doi:10.1038/s41586-019-1631-3 · Cited by 1,784 · see citing works
Regulatory T Cell-Derived Interleukin-10 Limits Inflammation at Environmental Interfaces
Rubtsov, Y. P., Rasmussen, J. P., Chi, E. Y., Fontenot, J., Castelli, L., Ye, X., Treuting, P., Siewe, L., Roers, A., Henderson, W. R., et al. (2008) · Immunity · doi:10.1016/j.immuni.2008.02.017 · Cited by 1,586 · see citing works
NASH limits anti-tumour surveillance in immunotherapy-treated HCC
Pfister, D., Núñez, N. G., Pinyol, R., Govaere, O., Pinter, M., Szydlowska, M., Gupta, R., Qiu, M., Deczkowska, A., Weiner, A., et al. (2021) · Nature · doi:10.1038/s41586-021-03362-0 · Cited by 1,294 · see citing works
A Special Population of Regulatory T Cells Potentiates Muscle Repair
Burzyn, D., Kuswanto, W., Kolodin, D., Shadrach, J. L., Cerletti, M., Jang, Y., Sefik, E., Tan, T. G., Wagers, A. J., Benoist, C., et al. (2013) · Cell · doi:10.1016/j.cell.2013.10.054 · Cited by 1,234 · see citing works
Self-citationPPAR-γ is a major driver of the accumulation and phenotype of adipose tissue Treg cells
Cipolletta, D., Feuerer, M., Li, A., Kamei, N., Lee, J., Shoelson, S. E., Benoist, C., & Mathis, D. (2012) · Nature · doi:10.1038/nature11132 · Cited by 1,143 · see citing works
Self-citationTreg cell-based therapies: challenges and perspectives
Raffin, C., Vo, L. T., & Bluestone, J. A. (2019) · Nature reviews. Immunology · doi:10.1038/s41577-019-0232-6 · Cited by 728 · see citing works
Wolf, M. J., Adili, A., Piotrowitz, K., Abdullah, Z., Boege, Y., Stemmer, K., Ringelhan, M., Simonavicius, N., Egger, M., Wohlleber, D., et al. (2014) · Cancer Cell · doi:10.1016/j.ccell.2014.09.003 · Cited by 678 · cited 1× · see citing works
“Hepatic CD8 + T cells, particularly a PD1 + CXCR6 + “auto-aggressive” subset, have been implicated as direct effectors of hepatocyte death (13, 14).”
Immune cell-mediated features of non-alcoholic steatohepatitis
Huby, T., & Gautier, E. L. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-021-00639-3 · Cited by 573 · cited 2× · see citing works
“It is by now well accepted that inflammation is an important element of MASH (12).”
An improved mouse model that rapidly develops fibrosis in non‐alcoholic steatohepatitis
Matsumoto, M., Hada, N., Sakamaki, Y., Uno, A., Shiga, T., Tanaka, C., Ito, T., Katsume, A., & Sudoh, M. (2013) · International Journal of Experimental Pathology · doi:10.1111/iep.12008 · Cited by 523 · cited 2× · see citing works
“The CDAHFD, which combines choline deprivation with a high - fat content and defined amino acid composition, elicits rapid - onset steatosis, inflammation, and fibrosis (20).”
Auto-aggressive CXCR6+ CD8 T cells cause liver immune pathology in NASH
Dudek, M., Pfister, D., Donakonda, S., Filpe, P., Schneider, A., Laschinger, M., Hartmann, D., Hüser, N., Meiser, P., Bayerl, F., et al. (2021) · Nature · doi:10.1038/s41586-021-03233-8 · Cited by 512 · cited 3× · see citing works
“Hepatic CD8 + T cells, particularly a PD1 + CXCR6 + “auto-aggressive” subset, have been implicated as direct effectors of hepatocyte death (13, 14).”
Gomes, A. L., Teijeiro, A., Burén, S., Tummala, K. S., Yilmaz, M., Waisman, A., Theurillat, J.-P., Perna, C., & Djouder, N. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.05.020 · Cited by 401 · see citing works
Wang, H., Zhang, H., Wang, Y., Brown, Z. J., Xia, Y., Huang, Z., Shen, C., Hu, Z., Beane, J., Ansa-Addo, E. A., et al. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.07.032 · Cited by 398 · cited 2× · see citing works
“Our results align with studies showing that ablation of Nr4a1 and Nr4a2 in T cells enhanced liver Treg accumulation and attenuated MASH pathology (19), but contrast with claims of a detrimental role for Tregs in MASH (18, 28).”
Akiyama, T. E., Sakai, S., Lambert, G. C., Nicol, C. J. B., Matsusue, K., Pimprale, S., Lee, Y., Ricote, M., Glass, C. K., Brewer, H. B., et al. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.8.2607-2619.2002 · Cited by 368 · cited 1× · see citing works
“Pparg flox mice (39).”
Kolodin, D., van Panhuys, N., Li, C., Magnuson, A. M., Cipolletta, D., Miller, C. M., Wagers, A., Germain, R. N., Benoist, C., & Mathis, D. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.03.005 · Cited by 365 · see citing works
Self-citationIdentification of a broadly fibrogenic macrophage subset induced by type 3 inflammation
Fabre, T., Barron, A. M. S., Christensen, S. M., Asano, S., Bound, K., Lech, M. P., Wadsworth, M. H., Chen, X., Wang, C., Wang, J., et al. (2023) · Science Immunology · doi:10.1126/sciimmunol.add8945 · Cited by 355 · cited 2× · see citing works
“These effects are reminiscent of the loss of control of autoaggressive CD8 + T cells previously implicated in antigen - independent hepatocyte killing (14), as well as the unleashing of IL - 17 - producing cells (15–17).”
Metabolic dysfunction-associated steatotic liver disease in adults
Huang, D. Q., Wong, V. W., Rinella, M. E., Boursier, J., Lazarus, J. V., Yki‐Järvinen, H., & Loomba, R. S. (2025) · Nature Reviews Disease Primers · doi:10.1038/s41572-025-00599-1 · Cited by 336 · cited 1× · see citing works
“M etabolic - dysfunction - a ssociated s teatoh epatitis (MASH) is a related but distinct inflammatory complication of the metabolic syndrome, characterized by steatosis, hepatocellular injury, immunocyte accumulation, and progressive fibrosis (11).”
Clapper, J. R., Hendricks, M. D., Gu, G., Wittmer, C., Dolman, C. S., Herich, J., Athanacio, J., Villescaz, C., Ghosh, S. S., Heilig, J. S., et al. (2013) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00079.2013 · Cited by 294 · cited 1× · see citing works
“In contrast, the AMLN diet, enriched in fat, fructose, and cholesterol, induces a slower but steadily progressive form of the disease, characterized by hepatocellular ballooning, chronic inflammation, and fibrotic remodeling (21).”
Tissue regulatory T cells: regulatory chameleons
Muñoz-Rojas, A. R., & Mathis, D. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-021-00519-w · Cited by 281 · see citing works
Self-citationTreg Enhancing Therapies to Treat Autoimmune Diseases
Eggenhuizen, P. J., Ng, B. H., & Ooi, J. D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197015 · Cited by 248 · cited 1× · see citing works
“…to expand or potentiate the Treg compartment, such as administration of low - dose IL - 2, engineered forms of IL - 2, IL - 33, or TNFR2 agonists (35), hold promise, but require precise targeting to avoid unintended proinflammatory Treg counterinfluences or effects on non - Treg populations.”
TCR Transgenic Mice Reveal Stepwise, Multi-site Acquisition of the Distinctive Fat-Treg Phenotype
Li, C., DiSpirito, J. R., Zemmour, D., Spallanzani, R. G., Kuswanto, W., Benoist, C., & Mathis, D. (2018) · Cell · doi:10.1016/j.cell.2018.05.004 · Cited by 231 · see citing works
Self-citationSpallanzani, R. G., Zemmour, D., Xiao, T., Jayewickreme, T., Li, C., Bryce, P. J., Benoist, C. O., & Mathis, D. J. (2019) · Science Immunology · doi:10.1126/sciimmunol.aaw3658 · Cited by 228 · see citing works
Self-citationLi, F., Hao, X., Chen, Y., Bai, L., Gao, X., Lian, Z., Wei, H., Sun, R., & Tian, Z. (2017) · Nature Communications · doi:10.1038/ncomms13839 · Cited by 191 · cited 2× · see citing works
“These effects are reminiscent of the loss of control of autoaggressive CD8 + T cells previously implicated in antigen - independent hepatocyte killing (14), as well as the unleashing of IL - 17 - producing cells (15–17).”
Gut CD4+ T cell phenotypes are a continuum molded by microbes, not by TH archetypes
Kiner, E., Willie, E., Vijaykumar, B., Chowdhary, K., Schmutz, H., Chandler, J. S., Schnell, A., Thakore, P. I., Gros, G. S. L., Mostafavi, S., et al. (2021) · Nature Immunology · doi:10.1038/s41590-020-00836-7 · Cited by 163 · cited 1× · see citing works
“Sequencing data were processed using the Cell Ranger pipeline (10× Genomics) and analyzed with the Seurat package following established workflows (31, 40).”
Self-citationA mechanism for expansion of regulatory T-cell repertoire and its role in self-tolerance
Feng, Y., van der Veeken, J., Shugay, M., Putintseva, E. V., Osmanbeyoglu, H. U., Dikiy, S., Hoyos, B. E., Moltedo, B., Hemmers, S., Treuting, P., et al. (2015) · Nature · doi:10.1038/nature16141 · Cited by 157 · see citing works
The gut microbiota promotes distal tissue regeneration via RORγ+ regulatory T cell emissaries
Hanna, B. S., Wang, G., Galván-Peña, S., Mann, A. O., Ramirez, R. N., Muñoz-Rojas, A. R., Smith, K., Wan, M., Benoist, C., & Mathis, D. (2023) · Immunity · doi:10.1016/j.immuni.2023.01.033 · Cited by 126 · cited 2× · see citing works
“Both reparative clusters expressed diagnostic Areg (encoding amphiregulin) and Il1rl1 (specifying the IL - 33 receptor, ST2) transcripts and were enriched for an established reparative - Treg signature ( SI Appendix , Table S1) (25).”
Self-citationSavage, T. M., Fortson, K. T., de los Santos-Alexis, K., Oliveras-Alsina, A., Rouanne, M., Rae, S. S., Gamarra, J. R., Shayya, H., Kornberg, A., Cavero, R., et al. (2024) · Immunity · doi:10.1016/j.immuni.2024.01.009 · Cited by 115 · cited 1× · see citing works
“Recent work has implicated Treg - derived amphiregulin in the activation of hepatic stellate cells and in fibrogenesis (29).”
Li, C., Wang, G., Sivasami, P., Ramírez, R. N., Zhang, Y., Benoist, C. O., & Mathis, D. J. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.06.007 · Cited by 112 · cited 1× · see citing works
“Obesity reduces the compartment of eVAT Tregs and compromises their function, thereby promoting adipose - tissue inflammation, insulin resistance, and other features of the “metabolic syndrome” (1, 5, 10).”
Self-citationLangston, P. K., Sun, Y., Ryback, B. A., Mueller, A. L., Spiegelman, B. M., Benoist, C. O., & Mathis, D. J. (2023) · Science Immunology · doi:10.1126/sciimmunol.adi5377 · Cited by 82 · cited 1× · see citing works
“Alongside their established roles in eVAT, exercised skeletal muscle, and systemic metabolic homeostasis (5, 26, 32–34), Tregs in the liver emerge as central regulators of the immunologic tone in MASH.”
Self-citationMeningeal regulatory T cells inhibit nociception in female mice
Midavaine, É., de Moraes, B. C., Benitez, J., Rodriguez-Rosado, S., Bráz, J. M., Kochhar, N. P., Eckalbar, W. L., Tian, L., Domingos, A. I., Pintar, J. E., et al. (2025) · Science · doi:10.1126/science.adq6531 · Cited by 58 · see citing works
Xiao, T., Langston, P. K., Muñoz-Rojas, A. R., Jayewickreme, T., Lazar, M. A., Benoist, C. O., & Mathis, D. J. (2022) · Science Immunology · doi:10.1126/sciimmunol.abl7641 · Cited by 50 · see citing works
Self-citationPPARγ marks splenic precursors of multiple nonlymphoid-tissue Treg compartments
Li, C., Muñoz-Rojas, A. R., Wang, G., Mann, A. O., Benoist, C. O., & Mathis, D. J. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2025197118 · Cited by 50 · cited 2× · see citing works
“Sequencing data were processed using the Cell Ranger pipeline (10× Genomics) and analyzed with the Seurat package following established workflows (31, 40).”
Self-citationInnate Control of Tissue-Reparative Human Regulatory T Cells
Lam, A. J., MacDonald, K. N., Pesenacker, A. M., Juvet, S. C., Morishita, K. A., Bressler, B., iGenoMed Consortium, Pan, J. G., Sidhu, S. S., Rioux, J. D., et al. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1801330 · Cited by 47 · cited 1× · see citing works
“However, it is also important to note that, while murine tissue - Tregs are a major source of amphiregulin, its expression in human Tregs is less pronounced (30), raising questions about the importance of this pathway in human MASH.”
Martin, O. P., Wallace, M. S., Oetheimer, C., Patel, H. B., Butler, E. C., Wong, L. P., Huang, P., Elbaz, J., Costentin, C., Salloum, S., et al. (2025) · Nature Immunology · doi:10.1038/s41590-025-02255-y · Cited by 45 · see citing works
Wang, G., Muñoz-Rojas, A. R., Spallanzani, R. G., Franklin, R. A., Benoist, C. O., & Mathis, D. J. (2024) · Immunity · doi:10.1016/j.immuni.2024.04.002 · Cited by 45 · see citing works
Self-citationMendoza, A., Bou-Puerto, R., Jara, J. S., Dikiy, S., Giovanelli, P., Correa, D., Manenti, S., Andretta, E. S., Dahia, C. L., & Rudensky, A. Y. (2025) · Science Immunology · doi:10.1126/sciimmunol.adz6869 · Cited by 25 · see citing works
The Nr4a family regulates intrahepatic Treg proliferation and liver fibrosis in MASLD models
Aki, D., Hayakawa, T., Srirat, T., Shichino, S., Ito, M., Saitoh, S.-I., Mise-Omata, S., & Yoshimura, A. (2024) · Journal of Clinical Investigation · doi:10.1172/jci175305 · Cited by 22 · cited 2× · see citing works
“Our results align with studies showing that ablation of Nr4a1 and Nr4a2 in T cells enhanced liver Treg accumulation and attenuated MASH pathology (19), but contrast with claims of a detrimental role for Tregs in MASH (18, 28).”
ATF4 drives regulatory T cell functional specification in homeostasis and obesity
Wang, K., Farrell, A., Zhou, E., Qin, H., Zeng, Z., Zhou, K., Rocha, K. C. E., Zhang, D., Wang, G., Atakilit, A., et al. (2025) · Science Immunology · doi:10.1126/sciimmunol.adp7193 · Cited by 12 · cited 1× · see citing works
“Our results align with studies showing that ablation of Nr4a1 and Nr4a2 in T cells enhanced liver Treg accumulation and attenuated MASH pathology (19), but contrast with claims of a detrimental role for Tregs in MASH (18, 28).”
Marin-Rodero, M., Jayewickreme, T., Benoist, C. O., & Mathis, D. J. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2518203122 · Cited by 2 · cited 1× · see citing works
“Through interactions with other immunocytes, stromal cells, and adipocytes, they suppress inflammation, regulate local and systemic metabolism, and control adipogenesis and lipolysis (5–9).”
Self-citation
Flagged first, then by citations
Research works printed but not linked: 1
- B. S. Hanna . Data from “Regulatory T cells safeguard liver health during metabolic-associated steatohepatitis”. GEO. https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE314148. Deposited 17 December 2025.
Cited by
Sorted by citations
Javidan, A., & Nikolajczyk, B. S. (2026) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.126.325469
Russi, A. E., & DeBosch, B. J. (2026) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2026.101899
- Authors
- Hanna, B. S., Langston, P. K., Marin-Rodero, M., Ramirez, R. N., Wan, M., Benoist, C., & Mathis, D.
- Affiliations
- Harvard University (US)
- Department of Immunology, Harvard Medical School
- Pfizer (United States) (US)
- Corresponding author
- Hanna, Bola S.
- Langston, P. Kent
- Mathis, Diane
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2026-02-17
- Volume
- 123
- Issue
- 8
- Pages
- e2536314123-e2536314123
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC12933153
- OpenAlex
- W7129423151
- Cited by
- 1
- References
- 40
- Citations by year
- 2026: 1
- FWCI
- 4.88
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- PubMed Central (submittedVersion, cc-by-nc-nd)
- Funders
- HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (DK092541)
- Pfizer Inc (NA)
- Freedom Together Foundation (NA)
- Topics
- Health Sciences › Medicine › Epidemiology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Single-cell and spatial transcriptomics
- Keywords
- regulatory T cells, nonalcoholic steatohepatitis, liver inflammation, immunometabolism, PPARγ, Foxp3, CD4+ T cells, Th1/Th2/Th17 responses
- MeSH terms
- Animals, Disease Models, Animal, Fatty Liver
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-09-28.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-09-28.
Cited sources are checked by gpt-6-sol.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review